Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7323 p642-643
30 October 2004

This article
Reprint   Photocopy

PDF 85K, Acrobat Reader

Letters

· Emergency supplies
· Education
· New contract
· Agenda for change
· CPD
· Retention fees
· Boots the Chemists
· The industry
· Aqueous cream
· Overseas members


Letters to the Editor

Retention fees

A club I do not think I want to join

Considering my position

The Council must revisit retention fees urgently

A club I do not think I want to join

From Mr W. B. Rhodes, FRPharmS

It was a brave attempt by the President (PJ, 23 October, p624) to try to explain why the Royal Pharmaceutical Society’s retention fees are set to increase by such a large amount. Although one could debate the entire subject this would be unproductive since the consultation period has now passed. However, his final sentence relating to non-practising members cannot pass unchallenged and I quote: “For those in hardship for whom the fees present difficulty the Benevolent Fund may be able to provide a source of support.” That, with respect, is nonsense.

There are thousands on the Register who could afford the increase but who cannot justify it and a large number who cannot afford the cost but who would not go through the hoop of applying to the Benevolent Fund. In the report of the August Council meeting we were advised that practising members can expect further significant increases over the next five years from the current proposed £256 (I hope that all members have appreciated this) and the non-practising fee will then be over £100. I have spoken to a variety of retired members including retired members of Council and a blind member who cannot even read The Journal and I have read all the members’ letters in The Journal, a good number of whom want to retain membership for sentimental reasons only but are on the point of withdrawal.

If it is the view of the Council that they want rather callously to get rid of those who have served the profession and the public all of their working lives in academia, community, hospital, industry, publishing and research, let alone any one-time administrators, and who because of their experience still have a contribution to make then rather like one of the Marx brothers this is a club that I do not think I want to join.

With great sadness ...

Bruce Rhodes
One-time Assistant Secretary of the Society,
Cheltenham, Gloucestershire


Considering my position

From Mr M. E. Q. James, FRPharmS

I am one of those retired members working less than 10 hours per week (the approximate equivalent of one week per month) and, as your editorial (PJ, 23 October, p588) suggested I would, I am considering my position. In my considerations I have to take account of several issues.

First, I want to maintain some contact with my profession. I have been a pharmacist for over 40 years and a fellow for almost 16. I have many friends in pharmacy.

Secondly, I like what I do, (medication review, either for individuals or for practices) but have no desire to do “conventional” locums. In any event I am not sure that I am competent to do so because it is over 10 years since I worked in a community pharmacy. However, the funding for such activities seems to be exhausted locally and in spite of the optimism expressed by various pharmaceutical bodies it does not seem as though the pot of gold is likely to be refreshed. I have a nasty suspicion that it is at the end of the rainbow!

Thirdly, I am informed (although both the President’s contribution [PJ, 23 October, p624] and the PJ generally have kept rather quiet about it) that it is intended that the non-practising fee will increase from the present reasonably modest £46 to the equivalent of 33 per cent of the full fee over a three-year period (PJ, 14 August, p233).

So, unless I can find another organisation that can use my pharmaceutical talents, what am I to do? I have no problem with doing continuing education or maintaining a continuing professional development file; indeed I am presently part of a project to review the education needs of primary care pharmacists, am booked to attend two relevant CPPE courses and am a branch secretary. My membership fee for the current year was £116. It looks to me at the moment as though I shall become non-practising next year and probably leave the register a year or so later when the non-practising fees rise to the sort of amount I am paying at the moment. Incidentally, my ex-teacher wife still gets her equivalent of the PJ for a nominal amount.

Miall E. James
Colchester


The Council must revisit retention fees urgently

From Mr M. R. Hickey, MRPharmS

I was one of the members of the Royal Pharmaceutical Society’s Council who voted against the proposed increases in the retention fees and, in common with the other members, have received considerable correspondence on the subject. When the decision was taken I was deeply unhappy about the scale of the increases and although I accepted the financial logic I thought it would be wrong to inflict such an increase, certainly not without first going out to the membership as a whole and explaining the rationale underpinning the process.

However, what left me most unhappy was the fact that the changes to the structure of the retention fee, in particular the increases to be applied to part-time and overseas pharmacists, were passed without any real debate. In fact the proposal to make these changes was only presented to the full Council a couple of hours before the decision was made. I thought that proper consideration and debate were impossible. In fact these changes passed, as I recall without a vote, after the 25 per cent increase had been debated, and it was debated heatedly.

It was put to the Council that the changes to the Register, to the categories of practising and non-practising, were necessary because it cost the same to regulate all pharmacists who practised, regardless of how many days, weeks or months they worked. If this were the case then surely it would cost the same to regulate a pharmacist as a technician, which is less than £100; if this is the case then the difference in fees must be made up by a payment required to fund membership services: technicians being regulants, pharmacists being regulants and members.

I realise that this is simplistic. However, I think there is a case for retaining certain categories of membership, in particular the part-time category. If I am away from my pharmacy then I expect my locums to be up to a minimum standard; all of them are much better than that, of course. I do not expect every locum to be able to fulfil every extended service that I provide, not everyone has the same training or relevant experience. A prescribing pharmacist may have to fulfil higher standards of CPD and revalidation than one who does not prescribe, but the latter does have to be able to fulfil the core functions of the job and that may require a more basic standard of CPD. Many of the part-time pharmacists I employ from time to time for holiday or sick cover fall into this latter category. If these pharmacists are to leave the register then I fear there will be a serious manpower shortage, and the novel and advanced services we would like to provide will prove to be mirages as we wilt under the pressure of overwork. It is bad enough finding locums at the moment without large numbers of pharmacists, most of whom work in community pharmacy, fleeing from the register.

It is easy to say “charge the employer extra” or “it is only equivalent to two days’ locum”, but a principle is at stake. The letters pages of the PJ have been full of commentary from august and venerated pharmacists saying they will leave the Register. It is no wonder because they must feel like they have been kicked in the teeth by the Council. We lose these members at our peril. It is not necessarily about the amount of money involved; it is simply about a sense of fairplay.

The other category of membership badly affected by the change made is that of overseas pharmacist. One member wrote to me thus: “It seems to me that we should give exceptional support to those members of our profession who have deliberately chosen to work towards the good health of citizens of developing countries and forgone the higher salaries available in the developed world.” I could not put it more succinctly. A sense of fair play would suggest that these pharmacists should not suffer an undue financial penalty.

The proposed change has gone to Privy Council to be ratified, but I would suggest that it would be to the credit of this Council if it were to draw back from the brink. The Council cannot inflict larger fees on the members than are contained in the Byelaws but it can, if it so decides, inflict less.

I know from discussions with other members of Council that several of those who voted for the changes are unhappy. They are unhappy on the grounds that there was insufficient debate before the decision was made; they are particularly unhappy in light of Karen Hassell’s research (PJ, 23 October, p625), which suggests to me that the number of part-time, industrial and overseas pharmacists leaving the register will be so significant that this year’s financial crisis will seem like the warming of air and mild breeze that precedes the storm. A proper debate at the time the decision was made might have teased these issues out.

I suggest that Council should revisit this issue urgently, and that it should seek to retain the status of part-time and overseas pharmacists within the practising register.

Maurice Hickey
Member of Council
Royal Pharmaceutical Society

Send your letter to The Editor

Previous Topic (CPD)
Next Topic (Boots the Chemists)


Back to Top


©The Pharmaceutical Journal